← All organizations

Henogen

For profit

Also known as: Shenzhen Hemogen

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 12, 2024

Acquired by Novasep on Jul 13, 2009

Timeline

1990s

Jun 1, 1999
Henogen— Founded

2000s

Jul 13, 2009
Novasep— Acquired By

Drugs by trial phase (6 distinct, 11 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

autologous hematopoietic stem cells

Indications

Studied for

Recent trials (17)

NCT06655662OfficialPhase 1Jun 12, 2024
NCT06655662Lead sponsorPhase 1Jun 12, 2024
NCT05851105Overall official - principal investigatorEarly Phase 1Oct 8, 2022
NCT05851105OfficialEarly Phase 1Oct 8, 2022
NCT05851105Lead sponsorEarly Phase 1Oct 8, 2022
NCT05864170Overall official - principal investigatorEarly Phase 1May 27, 2022
NCT05864170Lead sponsorEarly Phase 1May 27, 2022
NCT05745532Lead sponsorEarly Phase 1Dec 1, 2020
NCT05745532Overall official - principal investigatorEarly Phase 1Dec 1, 2020
NCT00640497Lead sponsorPhase 1/Phase 2Jan 1, 2010
NCT00480116Lead sponsorPhase 3Jan 1, 2008
NCT00445185Lead sponsorPhase 3Mar 1, 2007
NCT00430534Study directorPhase 2Feb 1, 2007
NCT00430534Lead sponsorPhase 2Feb 1, 2007
NCT00291980Lead sponsorPhase 3Mar 1, 2006

Details

Founded: Charleroi, BE Jun 1, 1999
Last known activity: Jun 12, 2024